Nilotinib in Cognitively Impaired Parkinson Disease Patients 001
NCT02281474
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Parkinson's Disease
Parkinson's Disease Dementia
Diffuse Lewy Body Disease
Interventions
DRUG:
Nilotinib
Sponsor
Georgetown University